Department of Pharmaceutical Sciences
College of Pharmacy
University of Nebraska Medical Center
Dr. Dong Wang was born and raised in Beijing, China. He received his PhD in polymer chemistry and physics from Peking University in 1998 under the mentorship of the late Professor Xin-de Feng, the founding father of polymer chemistry education in China. He then joined Professor Jindřich Kopeček’s laboratory at University of Utah for his postdoctoral training in pharmaceutical chemistry. After the appointment as a research assistant professor at Utah for 2 years, Dr. Wang joined University of Nebraska Medical Center (UNMC) early 2005 as a tenure-track assistant professor and was promoted to associate professor with tenure in 2008. In 2014, he was promoted to the rank of full professor. Dr. Wang’s research primarily focuses prodrug and nanomedicine development for inflammatory, musculoskeletal and craniofacial diseases. He has published close to 100 peer-reviewed manuscripts and numerous conference abstracts. As the lead inventor, Dr. Wang has over 30 PCT and US patents and patent applications, some of which have been licensed to the industry for further development and commercialization. He is also the co-founder of three start-up biotech companies focusing on translation and commercialization of drug candidates originated from his laboratory.
Dr. Jia graduated from Institute of Chemistry, Chinese Academy of Sciences (CAS) and obtained his PhD in Organic Chemistry in 2007. Then he moved to Shanghai Institute of Organic Chemistry and Kobe University in Japan for postdoctoral research. In 2011, Dr. Jia joined Dr. Dong Wang’s research lab and has been doing synthetic research for novel bioactive prodrugs for drug delivery on inflammatory diseases.
Xin graduated from Jilin University double majoring B.S. in Biotechnology and Chemistry, followed by a Ph. D. in Pharmaceutical Sciences in University of Nebraska Medical Center in 2018. Her research interests include the design, synthesis and characterization of polymeric nanomedicines for drug delivery, and the therapeutic evaluation for the treatment of musculoskeletal diseases, and healthy concerns for women and children. She is especially interested in the pharmacodynamic, pharmacokinetics and biodistribution of the nanomedicines. In her personal life, she enjoys yoga, taekwondo, swimming, and outdoor activities such as fishing, and hiking. She’s also a good cook as a chemist.
Zhifeng received his bachelor’s degree in Pharmaceutical Sciences from Fudan University, Shanghai, China. He was enrolled in UNMC as a PhD student in August 2017 and joined the lab in spring of 2018. His research focuses on prodrug nanomedicine development for kidney diseases, such as lupus nephritis and focal segmental glomerulosclerosis. He has extensive experience in animal studies from his work in the lab.
Ningrong received her B.Sc. from China Pharmaceutical University, Nanjing, China. (Nanjing is also her hometown.) She is now in her 4th year on Ph.D. track. She is mainly working on macromolecular prodrug application in the field of musculoskeletal diseases (fracture healing, osteoarthritis) and chronic pain relief. She loves traveling and exercising during her spare time.
Haochen received her B.Sc. from China Pharmaceutical University. She joined the lab in fall of 2019 pursuing her Ph.D. degree. Her current research focuses on prodrug nanomedicine development for lupus erythematosus with a focus on cutaneous lupus and also other kidney disease such as focal segmental glomerulosclerosis. She is very much a cat lover and is adventurous just like feline. She enjoys snowboarding, backcountry camping/ hiking and photography.
Roshni received her B.Tech in Biotechnology from SASTRA University, Tanjore, India. She is currently pursuing her master degree in the Department of Pharmaceutical Sciences at University of Nebraska Medical Center. Her research interest primarily lies in the area of drug delivery for inflammatory and infectious diseases. Her hobbies include watching movies and indulging in outdoor activities.